Truist upgraded National Health Investors (NHI) to Buy from Hold with an unchanged price target of $77. The analyst, who expects skilled nursing rent coverage and senior housing operating portfolio fundamentals to continue to improve, notes that National Health is one of the lowest-levered REITs in its coverage universe and still has among the highest forecasted three- and five-year earnings growth rates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors price target raised to $77 from $76 at Truist
- National Health Investors Updates Investment Pipeline Strategy
- National Health Investors Holds 2025 Annual Meeting
- National Health Investors issues statement in response to ISS recommendation
- Land & Buildings says ISS recommends NHI stockholders vote for director nominees